Literature DB >> 22085626

Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.

Gang Fang1, John M Brooks, Elizabeth A Chrischilles.   

Abstract

Instrumental variable (IV) and risk adjustment (RA) estimators, including propensity score adjustments, are both used to alleviate confounding problems in nonexperimental studies on treatment effects, but it is not clear how estimates based on these 2 approaches compare. Methodological considerations have shown that IV and RA estimators yield estimates of distinct types of causal treatment effects regardless of confounding problems. Many investigators have neglected these distinctions. In this paper, the authors use 3 schematic models to explain visually the relations between IV and RA estimates of intended treatment effects as demonstrated in the methodological studies. When treatment effects are homogeneous across a study population or when treatment effects are heterogeneous across the study population but treatment decisions are unrelated to the treatment effects, RA and IV estimates should be equivalent when the respective assumptions are met. In contrast, when treatment effects are heterogeneous and treatment decisions are related to the treatment effects, RA estimates of treatment effect can asymptotically differ from IV estimates, but both are correct even when the respective assumptions are met. Appropriate interpretations of IV or RA estimates can be facilitated by developing conceptual models related to treatment choice and treatment effect heterogeneity prior to analyses.

Entities:  

Mesh:

Year:  2011        PMID: 22085626     DOI: 10.1093/aje/kwr283

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs.

Authors:  Puttarin Kulchaitanaroaj; Barry L Carter; Amber M Goedken; Elizabeth A Chrischilles; John M Brooks
Journal:  Res Social Adm Pharm       Date:  2014-08-01

2.  Applying machine learning to predict real-world individual treatment effects: insights from a virtual patient cohort.

Authors:  Gang Fang; Izabela E Annis; Jennifer Elston-Lafata; Samuel Cykert
Journal:  J Am Med Inform Assoc       Date:  2019-10-01       Impact factor: 4.497

3.  Propensity score methods and unobserved covariate imbalance: comments on "squeezing the balloon".

Authors:  M Sanni Ali; Rolf H H Groenwold; Olaf H Klungel
Journal:  Health Serv Res       Date:  2014-01-24       Impact factor: 3.402

4.  Problems with public reporting of cancer quality outcomes data.

Authors:  Paul Goldberg; Rena M Conti
Journal:  J Oncol Pract       Date:  2014-05       Impact factor: 3.840

5.  Association between higher rates of cardioprotective drug use and survival in patients on dialysis.

Authors:  Yuexin Tang; John M Brooks; James B Wetmore; Theresa I Shireman
Journal:  Res Social Adm Pharm       Date:  2014-12-31

Review 6.  New methods for determining comparative effectiveness in rheumatoid arthritis.

Authors:  Huifeng Yun; Jeffrey R Curtis
Journal:  Curr Opin Rheumatol       Date:  2013-05       Impact factor: 5.006

7.  Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis.

Authors:  Bradley D McDowell; Cole G Chapman; Brian J Smith; Anna M Button; Elizabeth A Chrischilles; James J Mezhir
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

8.  What is the effect of area size when using local area practice style as an instrument?

Authors:  John M Brooks; Yuexin Tang; Cole G Chapman; Elizabeth A Cook; Elizabeth A Chrischilles
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

Review 9.  Instrumental Variable Analyses in Pharmacoepidemiology: What Target Trials Do We Emulate?

Authors:  Sonja A Swanson
Journal:  Curr Epidemiol Rep       Date:  2017-10-17

10.  Survival implications associated with variation in mastectomy rates for early-staged breast cancer.

Authors:  John M Brooks; Elizabeth A Chrischilles; Mary Beth Landrum; Kara B Wright; Gang Fang; Eric P Winer; Nancy L Keating
Journal:  Int J Surg Oncol       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.